» Articles » PMID: 35935998

IFN-I Inducible Targets ADAR1 Isoforms and Fine Tunes Innate Immune Activation

Overview
Journal Front Immunol
Date 2022 Aug 8
PMID 35935998
Authors
Affiliations
Soon will be listed here.
Abstract

Regulation of innate immune responses is essential for maintenance of immune homeostasis and development of an appropriate immunity against microbial infection. We show here that , product of the host gene, is induced by type I interferon (IFN-I) in several human non-immune and immune cell types, in particular in primary myeloid cells. Studies in HeLa cells showed that represses both p110 and p150 ADAR1 and reduces constitutive and IFN-induced A-to-I RNA editing. In line with this, activation of innate sensors and expression of IFN-β and the pro-inflammatory IL-6 are promoted. directly targets transcripts by binding to one specific site in the 3'UTR. Moreover, we could show that endogenous is associated with Ago2 and targets in IFN-stimulated cells. Overall, we propose that, by reducing ADAR1, IFN-I-induced contributes to lowering the activation threshold of innate sensors. Our findings provide new insights into the role of , placing it as a potential fine tuner of dsRNA metabolism, cell homeostasis and innate immunity.

Citing Articles

A Wonderful Journey: The Diverse Roles of Adenosine Deaminase Action on RNA 1 (ADAR1) in Central Nervous System Diseases.

Cheng L, Liu Z, Shen C, Xiong Y, Shin S, Hwang Y CNS Neurosci Ther. 2025; 31(1):e70208.

PMID: 39753993 PMC: 11702419. DOI: 10.1111/cns.70208.


Dual Role of microRNA-146a in Experimental Inflammation in Human Pulmonary Epithelial and Immune Cells and Expression in Inflammatory Lung Diseases.

Gronau L, Duecker R, Jerkic S, Eickmeier O, Trischler J, Chiocchetti A Int J Mol Sci. 2024; 25(14).

PMID: 39062931 PMC: 11276706. DOI: 10.3390/ijms25147686.


T cell dysfunction in elderly ARDS patients based on miRNA and mRNA integration analysis.

Mitsuyama Y, Matsumoto H, Togami Y, Oda S, Onishi S, Yoshimura J Front Immunol. 2024; 15:1368446.

PMID: 38571958 PMC: 10987699. DOI: 10.3389/fimmu.2024.1368446.

References
1.
Scagnolari C, Zingariello P, Vecchiet J, Selvaggi C, Racciatti D, Taliani G . Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha. Virol J. 2010; 7:311. PMC: 2996368. DOI: 10.1186/1743-422X-7-311. View

2.
George C, Ramaswami G, Li J, Samuel C . Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses. J Biol Chem. 2016; 291(12):6158-68. PMC: 4813567. DOI: 10.1074/jbc.M115.709014. View

3.
Baker A, Miliotis C, Ramirez-Moya J, Marc T, Vlachos I, Santisteban P . Transcriptome Profiling of ADAR1 Targets in Triple-Negative Breast Cancer Cells Reveals Mechanisms for Regulating Growth and Invasion. Mol Cancer Res. 2022; 20(6):960-971. PMC: 9177724. DOI: 10.1158/1541-7786.MCR-21-0604. View

4.
Li L, Zuo X, Liu D, Luo H, Zhang H, Peng Q . Plasma exosomal RNAs have potential as both clinical biomarkers and therapeutic targets of dermatomyositis. Rheumatology (Oxford). 2021; 61(6):2672-2681. DOI: 10.1093/rheumatology/keab753. View

5.
Ishizuka J, Manguso R, Cheruiyot C, Bi K, Panda A, Iracheta-Vellve A . Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. Nature. 2018; 565(7737):43-48. PMC: 7241251. DOI: 10.1038/s41586-018-0768-9. View